UPDATED: Janet Woodcock calls for independent investigation into Biogen and FDA relationships in unprecedented move
In the latest stunning chapter of the Biogen Aduhelm saga, acting FDA commissioner Janet Woodcock is calling for an investigation into the relationships between agency officials and Biogen executives.
Woodcock announced the move early Friday afternoon, posting a letter to the acting HHS Inspector General on Twitter.
Given the ongoing interest and questions, today I requested that @OIGatHHS conduct an independent review and assessment of interactions between representatives of Biogen and FDA during the process that led to the approval of Aduhelm. pic.twitter.com/iWJNxdZ5Cs
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 117,600+ biopharma pros reading Endpoints daily — and it's free.